2015
DOI: 10.1007/s13105-015-0405-0
|View full text |Cite|
|
Sign up to set email alerts
|

Nanocurcumin protects cardiomyoblasts H9c2 from hypoxia-induced hypertrophy and apoptosis by improving oxidative balance

Abstract: Hypoxia-induced cardiomyocyte hypertrophy is evident; however, the distinct molecular mechanism underlying the oxidative stress-mediated damages to cardiomyocytes remains unknown. Curcumin (diferuloylmethane) is known for anti-hypertrophic effects, but low bioavailability makes it unsuitable to exploit its pharmacological properties. We assessed the efficacy of nanotized curcumin, i.e. nanocurcumin, in ameliorating hypoxia-induced hypertrophy and apoptosis in H9c2 cardiomyoblasts and compared it to curcumin. H… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
20
0

Year Published

2015
2015
2024
2024

Publication Types

Select...
9
1

Relationship

2
8

Authors

Journals

citations
Cited by 29 publications
(22 citation statements)
references
References 41 publications
2
20
0
Order By: Relevance
“…Moreover, Nanocurcumin ameliorated hypoxia-induced hypertrophy and apoptosis in H9c2 cells by stabilizing HIF-1α protein and accumulation (Nehra et al, 2015). This could be the mechanism through which curcumin induces EPO expression in the current study.…”
Section: Discussionsupporting
confidence: 53%
“…Moreover, Nanocurcumin ameliorated hypoxia-induced hypertrophy and apoptosis in H9c2 cells by stabilizing HIF-1α protein and accumulation (Nehra et al, 2015). This could be the mechanism through which curcumin induces EPO expression in the current study.…”
Section: Discussionsupporting
confidence: 53%
“…A significant increase in its bioaccessibility was also obtained by excipient food emulsions technique (Zou et al, 2015) and nanotized curcumin (Nehra et al, 2015).…”
Section: A N U S C R I P Tmentioning
confidence: 94%
“…Nehra et al evaluated the effect of nanocurcumin after hypoxia. H9c2 cardiomyocytes treated with nanocurcumin (50 µM), compared to cells treated with curcumin, showed reduced hypertrophy and apoptosis [135]. In addition, nanocurcumin (50 ng/mL) inhibited the hypertrophy, reduced necrosis and ROS generation, restored the mitochondrial membrane potential and glucose transporters and increased ATP levels in primary human ventricular cardiomyocytes (HVCM) [136].…”
Section: In Vitro Effects Of Polyphenols Against Oxidative Stress-mentioning
confidence: 99%